181 related articles for article (PubMed ID: 16892345)
1. A medicinal-chemistry-guided approach to selective and druglike sigma 1 ligands.
Corbera J; Vaño D; Martínez D; Vela JM; Zamanillo D; Dordal A; Andreu F; Hernandez E; Perez R; Escriche M; Salgado L; Yeste S; Serafini MT; Pascual R; Alegre J; Calvet MC; Cano N; Carro M; Buschmann H; Holenz J
ChemMedChem; 2006 Jan; 1(1):140-54. PubMed ID: 16892345
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands.
Moussa IA; Banister SD; Beinat C; Giboureau N; Reynolds AJ; Kassiou M
J Med Chem; 2010 Aug; 53(16):6228-39. PubMed ID: 20662542
[TBL] [Abstract][Full Text] [Related]
5. (+)-cis-N-ethyleneamino-N-normetazocine derivatives. Novel and selective sigma ligands with antagonist properties.
Ronsisvalle G; Marrazzo A; Prezzavento O; Pasquinucci L; Vittorio F; Pittalà V; Pappalardo MS; Cacciaguerra S; Spampinato S
J Med Chem; 1998 May; 41(10):1574-80. PubMed ID: 9572883
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel N,N'-disubstituted piperazines as sigma receptor ligands.
Zhang Y; Williams W; Torrence-Campbell C; Bowen WD; Rice KC
J Med Chem; 1998 Dec; 41(25):4950-7. PubMed ID: 9836612
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2).
Rossi D; Urbano M; Pedrali A; Serra M; Zampieri D; Mamolo MG; Laggner C; Zanette C; Florio C; Schepmann D; Wuensch B; Azzolina O; Collina S
Bioorg Med Chem; 2010 Feb; 18(3):1204-12. PubMed ID: 20045339
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N'-benzylpiperazines: Potent ligands for sigma1 and sigma2 receptors.
Nahas RI; Lever JR; Lever SZ
Bioorg Med Chem; 2008 Jan; 16(2):755-61. PubMed ID: 18029187
[TBL] [Abstract][Full Text] [Related]
9. Novel sigma receptor ligands: synthesis and biological profile.
Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability.
Grosse Maestrup E; Wiese C; Schepmann D; Hiller A; Fischer S; Scheunemann M; Brust P; Wünsch B
Bioorg Med Chem; 2009 May; 17(10):3630-41. PubMed ID: 19394833
[TBL] [Abstract][Full Text] [Related]
11. 3-Methoxylphenylpropyl amides as novel receptor subtype-selective melatoninergic ligands: characterization of physicochemical and pharmacokinetic properties.
Zhu J; Hu Y; Ho MK; Wong YH
Xenobiotica; 2011 Jan; 41(1):35-45. PubMed ID: 21110748
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
[TBL] [Abstract][Full Text] [Related]
13. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of chiral 1-[omega-(4-chlorophenoxy)alkyl]-4-methylpiperidines and their biological evaluation at sigma1, sigma2, and sterol delta8-delta7 isomerase sites.
Berardi F; Loiodice F; Fracchiolla G; Colabufo NA; Perrone R; Tortorella V
J Med Chem; 2003 May; 46(11):2117-24. PubMed ID: 12747784
[TBL] [Abstract][Full Text] [Related]
15. Substituted benzylaminoalkylindoles with preference for the sigma2 binding site.
Mamolo MG; Zampieri D; Zanette C; Florio C; Collina S; Urbano M; Azzolina O; Vio L
Eur J Med Chem; 2008 Oct; 43(10):2073-81. PubMed ID: 18069094
[TBL] [Abstract][Full Text] [Related]
16. N-[omega-(Tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine are highly potent and selective sigma1 or sigma2 ligands.
Berardi F; Santoro S; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1998 Oct; 41(21):3940-7. PubMed ID: 9767631
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-affinity relationships of novel spirocyclic sigma receptor ligands with furopyrazole structure.
Schläger T; Schepmann D; Würthwein EU; Wünsch B
Bioorg Med Chem; 2008 Mar; 16(6):2992-3001. PubMed ID: 18221879
[TBL] [Abstract][Full Text] [Related]
19. Chiral, nonracemic (piperazin-2-yl)methanol derivatives with sigma-receptor affinity.
Bedürftig S; Wünsch B
Bioorg Med Chem; 2004 Jun; 12(12):3299-311. PubMed ID: 15158798
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
